Board of Directors

Our board are entrepreneurial and inspirational. Leading by example, they take the initiative, encourage innovation, manage risk and embrace new ideas. The board have extensive, varied and proven ion channel expertise and drug discovery knowledge.

Keith McCullagh PhD

Non-Executive Chairman
Keith McCullagh is an experienced pharmaceutical research & development executive and bioscience entrepreneur...

Andrew Southan PhD

Chief Executive Officer
Andy has over 30 years’ experience in life science research, including 23 years in the CRO sector...

Clare Rutty

Chief Financial Officer
Clare is an experienced CIMA qualified Accountant and completed a degree in Mathematics and Statistics...

John Ford PhD

Non-executive Director
John has almost 20 years of fundraising, ion channel, drug discovery and drug development experience...

John Montana PhD

Non-executive Director
A medicinal chemist by training, John Montana brings over 30 years’ experience in drug discovery and early development...

Steve Carle

Investor Director
Steve is an experienced private equity and development capital specialist having enjoyed a successful 30+ year career...

David Milroy

Investor Director
David is a Partner at Maven Capital Partners where he is a member of Maven’s Investment Committee...

Sunil Shah

Board Observer
Sunil Shah is a Board Observer at Metrion Biosciences and the CEO of the o2h Group...
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram